Related Experiment Video
Updated: Jun 5, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
[Agranulocytosis/granulocytopenia after long-term use of thiamazole]
Margriet Stellingwerf1, Wilbert T Jellema, Ingo A Eland
1St. Antonius ziekenhuis, afd. Interne Geneeskunde, Nieuwegein, the Netherlands.
Abstract:
Agranulocytosis/granulocytopenia is a rare side effect of thyreostatics. Earlier publications state that for thiamazole this side effect occurs during the first few months of treatment. In two patients this thiamazole-induced agranulocytosis/granulocytopenia only occurred after years of treatment. A 53-year-old man presented with fever after a visit to Suriname. He had used thiamazole for 12 years for Graves' hyperthyroidism. The second patient, a 31-year-old woman, presented at the emergency department with fever and sore throat after 13 years of intermittent treatment with thiamazole. Both patients had an agranulocytosis/granulocytopenia and leukopenia. This was thought to be a side effect of thiamazole and blood values normalised after cessation of therapy. Both patients were treated empirically with broad-spectrum antibiotics during the agranylocytic period. They then received radioactive sodium iodide. To our knowledge this case report is the first to describe agranulocytosis/granulocytopenia following long-term treatment with thiamazole.
Related Concept Videos
Drug toxicity: Idiosyncratic Reactions
Graves Disease II: Pathophysiology
Graves' Disease I: Introduction
Antiprotozoal Agents
Drug Toxicity: Dose-Dependent Reactions
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents